Omkar Pharmachem Limited

BSE:532167 Stock Report

Market Cap: ₹292.3m

Omkar Pharmachem Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Bhawani Goyal

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure4.8yrs
CEO ownershipn/a
Management average tenureless than a year
Board average tenure9yrs

Recent management updates

Recent updates

CEO

Bhawani Goyal (43 yo)

4.8yrs

Tenure

Mr. Bhawani Shankar Goyal has been Managing Director and Director of Omkar Pharmachem Limited since February 14, 2020. Mr. Goyal holds Bachelor Degree in Commerce from Maharshi Dayanand University, Rohtak...

Leadership Team

NamePositionTenureCompensationOwnership
Arun Kumar
Chief Financial Officerless than a year₹144.77kno data
Bhawani Goyal
MD & Director4.8yrsno datano data
Shivam Karotiya
Company Secretary & Compliance Officerless than a yearno datano data

1.0yrs

Average Tenure

43yo

Average Age

Experienced Management: 532167's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Bhawani Goyal
MD & Director4.8yrsno datano data
Parminder Sharma
Non-Executive Director21.1yrsno data0.35%
₹ 1.0m
Mamta Pachauri
Independent Woman Director9.3yrsno datano data
Janak Sharma
Independent Director8.8yrsno data0.64%
₹ 1.9m

9.0yrs

Average Tenure

52.5yo

Average Age

Experienced Board: 532167's board of directors are considered experienced (9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 04:20
End of Day Share Price 2024/11/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Omkar Pharmachem Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution